The BioPlex 2200 anti-CCP test, based on Axis-Shield’s anti-CCP technology, can be used for the early detection of rheumatoid arthritis. The assay measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have good specificity in the diagnosis of rheumatoid arthritis.
The measurement of these antibodies is claimed to have recently been cited as a key parameter in the definitive diagnosis of rheumatoid arthritis by the American College of Rheumatology.
The BioPlex 2200 system is an automated, random-access multiplex testing platform with an assay menu targeting autoimmune diagnostics and infectious diseases. The anti-CCP kit is pending clearance by the US FDA.
Phone: 0011 1 510 724 7000
Maxwell Biosystems MaxTwo high-density microelectrode array (HD-MEA) system
The next-generation multiwell HD-MEA captures high-quality signals at subcellular resolution from...
Enzo Life Sciences PROTEOSTAT Protein refolding and aggregation sensing kit
The kit includes a comprehensive set of optimised screening reagents and conditions that...
Bio-Rad Laboratories ddPLEX ESR1 Mutation Detection Kit
The kit enables simultaneous detection, discrimination and absolute quantification of seven known...
